Adaphostin is a novel activator of Fas-mediated death pathway in Bcr/Abl-positive leukaemia. References: Rivera-Del Valle N, Cheng T, Irwin ME, Donnella H, Singh MM, Chandra J. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol. 2018 Mar;81(3):483-495. doi: 10.1007/s00280-017-3509-0. Epub 2018 Jan 8. PubMed PMID: 29313067; PubMed Central PMCID: PMC5837827.

纯度：≥98%

CAS：241127-58-2